William W. Ericson
CIK 1503381 · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
FUEL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 550
SAN MATEO, CA 94404
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PACB | Director | 4,890,013 | $2.06 | $10.07M | $3.92M | 34 | 2026-06-04 |
| Adamas Pharmaceuticals Inc (ADMS) Delisted | Director | 0 | $8.22 | $0 | -$493.0K | 19 | 2021-11-24 |
| Rocket Fuel Inc. (FUEL) Delisted | Director | 9,295,955 | — | — | -$114.03M | 7 | 2017-09-06 |
Recent Filings · Page 4 of 7
61 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-10 | Rocket Fuel Inc. (FUEL) Delisted | Grant (A) | +8,854 | $0 | EDGAR |
| 2015-06-01 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Sell (S) | −119,556 | -$2.15M | EDGAR |
| 2015-05-21 | PACB | Grant (A) | — | $0 | EDGAR |
| 2015-05-20 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Sell (S) | −1,643 | -$29.6K | EDGAR |
| 2015-05-18 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-14 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Sell (S) | −37,078 | -$688.1K | EDGAR |
| 2015-03-19 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Sell (S) | −11,723 | -$211.3K | EDGAR |
| 2014-08-21 | PACB | Buy (P) | +146,265 | $698.1K | EDGAR |
| 2014-08-21 | PACB | Buy (P) | +114,321 | $530.4K | EDGAR |
| 2014-08-21 | PACB | Buy (P) | +39,299 | $202.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.